BMS-754807

DRUG6 trials

Sponsors

Bristol-Myers Squibb

Conditions

Advanced Solid TumorsBreast CancerColorectal CancerHead and Neck CancerMetastasesMetastatic Solid TumorsNeoplasm MetastasisNeoplasms

Phase 1

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

CompletedNCT00569036

Bristol-Myers SquibbMetastases, Neoplasms, Solid Tumors

Start: 2008-04-30End: 2013-04-30Updated: 2013-08-14

Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer

CompletedNCT00788333

Bristol-Myers SquibbBreast Cancer

Start: 2009-07-31End: 2011-11-30Updated: 2012-07-13

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors

CompletedNCT00793897

Bristol-Myers SquibbAdvanced Solid Tumors, Metastatic Solid Tumors

Start: 2009-04-30End: 2012-06-30Updated: 2012-07-13

Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan

CompletedNCT00898716

Bristol-Myers SquibbNeoplasms

Start: 2009-09-30End: 2011-07-31Updated: 2011-11-30

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

TerminatedNCT00908024

Bristol-Myers SquibbColorectal Cancer, Head and Neck Cancer, Neoplasm Metastasis

Start: 2009-10-31End: 2012-12-31Updated: 2013-06-18

Phase 2

Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors

TerminatedNCT01225172

Bristol-Myers SquibbBreast Cancer

Start: 2010-12-31End: 2014-11-30Updated: 2020-08-11